The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Organon & Co shares valued at $100,591 were purchased by COX CARRIE SMITH on May 14 ’25. At $8.07 per share, COX CARRIE SMITH acquired 12,469 shares. The insider’s holdings grew to 12,469 shares worth approximately $0.12 million following the completion of this transaction.
Also, Falcione Aaron purchased 5,500 shares, netting a total of over 48,235 in proceeds. Following the buying of shares at $8.77 each, the insider now holds 62,974 shares.
Before that, Weaver Kirke had added 8,045 shares to its account. In a trade valued at $74,054, the Gen. Counsel & Corp. Secy. bought Organon & Co shares for $9.21 each. Upon closing the transaction, the insider’s holdings increased to 8,045 shares, worth approximately $0.52 million.
As published in a research note from Evercore ISI on May 02, 2025, Organon & Co [OGN] has been rated down from an Outperform to an In-line. Analysts at JP Morgan downgraded the stock from ‘”a Neutral”‘ to ‘”an Underweight”‘ outlook in a report released in early September. As of November 03, 2023, Goldman has decreased its “Buy” rating to a “Neutral” for OGN. Earlier on September 21, 2023, Barclays initiated its rating. Their recommendation was “an Overweight” for OGN stock.
Analyzing OGN Stock Performance
On last trading session,, Organon & Co [NYSE: OGN] rose 0.50% to $10.0. The stock’s lowest price that day was $9.7262, but it reached a high of $10.115 in the same session. During the last five days, there has been a surge of approximately 1.52%. Over the course of the year, Organon & Co shares have dropped approximately -52.02%. Shares of the company reached a 52-week high of $17.23 on 02/13/25 and a 52-week low of $8.01 on 05/14/25.
Support And Resistance Levels for Organon & Co (OGN)
According to the 24-hour chart, there is a support level at 9.78, which, if violated, would cause prices to drop to 9.56. In the upper region, resistance lies at 10.17. The next price resistance is at 10.34. RSI (Relative Strength Index) is 53.59 on the 14-day chart, showing neutral technical sentiment.
Is Organon & Co subject to short interest?
Stocks of Organon & Co saw a sharp steep in short interest on 2025-05-30 dropping by -2.21 million shares to 17.49 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 19.7 million shares. A decline of -12.65% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.04 of the overall float, the days-to-cover ratio (short ratio) decline to 2.04.
Which companies own the most shares of Organon & Co (OGN)?
In terms of Organon & Co share price expectations, FactSet research, analysts set an average price target of 14 in the next 12 months, up nearly 40.7% from the previous closing price of $9.95. Analysts anticipate Organon & Co stock to reach 18 by 2025, with the lowest price target being 10. In spite of this, 3 analysts ranked Organon & Co stock as Buy at the end of 2025. On March 16, 2023, Raymond James assigned a price target of “an Outperform” to the stock and initiated coverage with a $33.
